Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.
Download presentation - Emerging role of Diagnostics HTA’s in Europe
Broadening access for innovative diagnostic solutions - EuroMedLab presentation
Payer Trends in Diagnostics & Digital Health – What’s new?
Last year we released a blog post on 5 recent Payer trends in Diagnostics. What are the latest developments? Check out this short summary:
Growing appetite for diagnostics health technology assessment in Europe
Joint (regulator-payer) evidence reviews and scientific advice to MedTech manufacturers gain further momentum in the US
Payers start to embrace Digital Health
(VIDEO) 3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access
3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access
The diagnostics industry is facing increasing policy attention. Policymakers push for broader access, better affordability and safer than ever solutions. Institutions, like the European Union (EU) and World Health Organization (WHO), are involved in introducing new regulations.
Find out what are the latest policy initiatives and how will they impact access for IVD solutions.
Five Diagnostics (IVD) Access Challenges & Potential Actions
WHO's Essential Diagnostics List in a 2-minute video
If a picture is worth a thousand Words, what is a video worth?
We took a complex topic, WHO's Essential Diagnostics List and condensed it in a 2-minute video...What do you think about the format and content?
Please comment.
Thanks Norbert
5 Payer trends in Diagnostics
In Vitro Diagnostics is going through exciting times. Pricing, reimbursement, policy topics are getting more and more relevant in the industry.
We have summarized 5 recent Payer trends, shaping the industry.
Do you want to have the collection of the supporting trend examples, please drop us a line.
Do you see other relevant trends that we might have missed, please comment.
CENTIVIS awarded ‘Approved Facilitator’ status for NICE META Tool
CENTIVIS awarded ‘Approved Facilitator’ status for latest NICE META Tool
CENTIVIS has recently been approved by NICE (National Institute for Health and Care Excellence) as one of the limited number of qualified Medtech Early Technical Assessment (META) Tool facilitators.
NICE has developed the META tool to help medical technology developers understand what evidence is needed to make a convincing case to payers and commissioners.
"With NICE META tool our diagnostics and digital health clients will benefit from a structured, streamlined and affordable evidence review to better capture the value of their diagnostic and digital health solutions"
Do you want to know more? SCHEDULE A CALL or visit the product page
Norbert